市场调查报告书
商品编码
1433321
2023-2030 年全球视讯喉镜市场Global Video Laryngoscope Market 2023-2030 |
预计在预测期内(2023-2030年),全球视讯喉镜市场将以9.2%的CAGR成长。视讯喉镜是一种用于可视化气道并促进气管插管的医疗设备。它由一个摄影机和一个插入口腔或鼻子并进入咽部的刀片组成。摄影机将气道影像传输到监视器,使临床医生能够清楚地看到声门和其他气道结构。由于多种原因,包括全球糖尿病盛行率上升,该市场正在以相当快的速度成长。根据世界卫生组织(WHO)统计,全球约有4.22亿人患有糖尿病,其中大多数生活在低收入和中等收入国家,每年有150万人直接死于糖尿病。在过去的几十年里,糖尿病的病例数和盛行率都在稳定增加。全球商定的目标是到 2025 年遏止糖尿病和肥胖症的增加。
全球视讯喉镜市场按类型、可用性和最终用户进行细分。根据类型,市场分为刚性和柔性。根据可用性,市场分为一次性和可重复使用。根据最终用户,市场被细分为医院、诊所和其他。在可用性方面,可重复使用的细分市场预计将占据相当大的市场份额,因为与传统喉镜相比,它易于使用且功能更强大,因此受到青睐。
其中,刚性子细分市场预计将在全球视讯喉镜市场中占据相当大的份额。这种细分增长归因于几个因素,例如它比柔性视讯喉镜更耐用且更容易控制。刚性视讯喉镜通常用于气道困难的情况,例如当患者张口受限或气道狭窄时。公司正致力于改进这些设备并引入更好的技术以获得更好的结果。例如,Dilon Technologies Inc. 宣布推出 CoPilot VL+ 视讯喉镜,这是一种气道管理设备,旨在帮助提供者在放置呼吸管时获得气道的最佳视野。新设备拥有更大、更亮、更高解析度的显示器以及强大的 LED,可帮助使用者更好地观察气道。 Dilon 表示,CoPilot VL+ 视讯喉镜结构紧凑、便于携带,这使其成为各种医疗环境的理想选择,例如手术室、重症监护室或紧急医疗响应领域的麻醉。
全球视讯喉镜市场根据地理位置进一步细分,包括北美(美国和加拿大)、欧洲(英国、义大利、西班牙、德国、法国和欧洲其他地区)、亚太地区(印度、中国、日本) 、韩国和亚洲其他地区)以及世界其他地区(中东和非洲以及拉丁美洲)。其中,预计北美将在全球市场中占据显着份额,因为人们对视讯喉镜的好处的认识不断增强,医生和患者也越来越意识到视讯喉镜的好处,例如提高成功率,减少併发症,缩短住院时间。
在所有地区中,亚太地区预计在预测期内将以相当大的CAGR成长。区域成长归因于人口老化以及肥胖和糖尿病等慢性病发病率的上升,该地区困难气道盛行率不断上升。根据亚太地区经济合作暨发展组织 (OECD) 的数据,约有 2.27 亿人患有第 2 型糖尿病,其中约一半未得到诊断,也不知道自己正在发展长期併发症。糖尿病导致全球 150 万人死亡,另有 220 万人死亡与高于最佳血糖有关。
服务视讯喉镜市场的主要公司包括Flexicare Medical LTD、Infinium Medical, Inc.、Intersurgical Ltd、Karl Storz Se & Co. KG、Medtronic、Nihon Kohden Corp、Prodol Meditec、Roper Technologies, Inc.、深圳HugeMed 医疗技术开发有限公司.、有限公司等。市场参与者透过各种策略(包括併购、合作、合作、融资和新产品发布),为市场成长做出了巨大贡献,以保持市场竞争力。例如,2021 年 5 月,Ambu 获得美国 FDA 批准 VivaSight 2 DLT。这使得该公司能够将该产品商业化,并扩展了其一次性肺科产品阵容。
Global Video laryngoscope Market Size, Share & Trends Analysis Report by Type (Rigid and Flexible), by Usability (Disposable and Reusable), and by End User (Hospitals, Clinics and Others), Forecast Period (2023-2030)
The global video laryngoscope market is anticipated to grow at a CAGR of 9.2% during the forecast period (2023-2030). Video laryngoscope is a medical device used to visualize the airway and facilitate endotracheal intubation. It consists of a camera and a blade that are inserted into the mouth or nose and advanced into the pharynx. The camera transmits images of the airway to a monitor, allowing the clinician to clearly see the glottis and other airway structures. And the market is growing at considerable rate owing to several reasons, including rising prevalence of diabetes globally. According to world health organization (WHO), About 422 million people worldwide have diabetes, the majority living in low-and middle-income countries, and 1.5 million deaths are directly attributed to diabetes each year. Both the number of cases and the prevalence of diabetes have been steadily increasing over the past few decades. There is a globally agreed target to halt the rise in diabetes and obesity by 2025.
The global video laryngoscope market is segmented on the type, usability, and end-user. Based on the type, the market is sub-segmented into rigid and flexible. Based on usability, the market is sub-segmented into disposable and reusable. And based on the end-user, the market is sub-segmented into hospitals, clinics and others. Among the Usability, the reusable sub-segment is anticipated to hold a considerable share of the market, owing to its preference due to its easy to use and greater functionality compared to traditional laryngoscopes.
Among the type, the rigid sub-segment is expected to hold a considerable share of the global Video laryngoscope market. This segmental growth is attributed to several factor such as, it is more durable and easier to control than a flexible video laryngoscope. Rigid video laryngoscopes are often used in difficult airway situations, such as when the patient has a limited mouth opening or a narrow airway. Companies are focusing on improving these devices and introducing better technology for better results. For instance, Dilon Technologies Inc. announced the launch of the CoPilot VL+ video laryngoscope, an airway management device developed to help providers have the optimum view of the airway when placing breathing tubes. The new device boasts a larger, brighter, higher resolution display along with powerful LEDs to help the user obtain a better view of the airway. The CoPilot VL+ video laryngoscope is compact and portable, which makes it ideal for every medical setting, according to Dilon, such as anesthesia in the operating room, intensive care unit or the emergency medical responder field.
The global Video laryngoscope market is further segmented based on geography including North America (the US, and Canada), Europe (UK, Italy, Spain, Germany, France, and the Rest of Europe), Asia-Pacific (India, China, Japan, South Korea, and Rest of Asia), and the Rest of the World (the Middle East & Africa, and Latin America). Among these, North America is anticipated to hold a prominent share of the market across the globe, owing to growing awareness of the benefits of video laryngoscopes, doctors and patients are becoming more aware of the benefits of video laryngoscopes, such as improved success rates, reduced complications, and shorter hospital stays.
Among all regions, the Asia Pacific regions is anticipated to grow at a considerable CAGR over the forecast period. Regional growth is attributed to the rising prevalence of difficult airways is increasing in the region, owing to the aging population and the rising incidence of chronic diseases such as obesity and diabetes. According to the Organization for Economic Cooperation and Development (OECD), Asia-Pacific, about 227 million people live with type 2 diabetes and about half of them are undiagnosed and unaware of developing long-term complications. diabetes caused 1.5 million deaths worldwide and an additional 2.2 million deaths were related to higher-than-optimal blood glucose.
The major companies serving the video laryngoscope market include Flexicare Medical LTD, Infinium Medical, Inc., Intersurgical Ltd, Karl Storz Se & Co. KG, Medtronic, Nihon Kohden Corp, Prodol Meditec, Roper Technologies, Inc, Shenzhen HugeMed Medical Technology Development Co., Ltd, and others. The market players are considerably contributing to the market growth by the adoption of various strategies including mergers and acquisitions, partnerships, collaborations, funding, and new product launches, to stay competitive in the market. For instance, In May 2021, Ambu received US FDA clearance for VivaSight 2 DLT. This enabled the company to commercialize the product and extended its single-use pulmonology lineup.